reference/30917941

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30917941

Outgoing Links

Predicate	Object
contentType	Case Reports\|Letter
endingPage	e96
issn	0145-2126
issueIdentifier	4
pageRange	e94-e96
publicationName	Leukemia Research
startingPage	e94
bibliographicCitation	Véronèse L, Tchirkov A, Richard-Pebrel C, Ledoux-Pilon A, Fleury J, Chaleteix C, Goumy C, Gouas L, Berger MG, Vago P, Bay JO, Tournilhac O. A thrombocytosis occurring in Philadelphia positive CML in molecular response to imatinib can reveal an underlying JAK2(V617F) myeloproliferative neoplasm. Leuk Res. 2010 Apr;34(4):e94–6. doi: 10.1016/j.leukres.2009.09.025. PMID: 19833389.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca8a53509ff6e084902a232b623a7052 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_779a45e207a33c384a156e078a94343b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef3d2e716b124c69d939cde8b6fbae17 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_290d95ee45b5d8e79c8afd2bbd417180 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c69955742d7f38ea6c275cf721316ed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c4130aaf9a101740aab93dd5663f44f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75d01649f3e7671877198a43e829d335 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff56ef5261a30a36f62cfa84ee4d11df http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7528a4acb9096c5e0f2395a7e0792941 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_555b403f78d1d890a811281c3c6c2185 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a3c997876186d20c0449a67d5275634 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_acb8e2e6c81770090784ba77d89d9fd1
date	201004
identifier	https://pubmed.ncbi.nlm.nih.gov/19833389 https://doi.org/10.1016/j.leukres.2009.09.025
isPartOf	https://portal.issn.org/resource/ISSN/0145-2126 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5304
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A thrombocytosis occurring in Philadelphia positive CML in molecular response to imatinib can reveal an underlying JAK2(V617F) myeloproliferative neoplasm
discusses	http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0016544 http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0022497 http://id.nlm.nih.gov/mesh/M0473784 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0391958 http://id.nlm.nih.gov/mesh/M0203030 http://id.nlm.nih.gov/mesh/M0016884
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009196Q000175 http://id.nlm.nih.gov/mesh/D015464Q000188 http://id.nlm.nih.gov/mesh/D053614Q000235 http://id.nlm.nih.gov/mesh/D011743Q000627 http://id.nlm.nih.gov/mesh/D010879Q000627 http://id.nlm.nih.gov/mesh/D019008Q000502 http://id.nlm.nih.gov/mesh/D013922Q000139
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D019008Q000235 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000068877 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015464Q000150 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D010649Q000235 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D019943Q000502 http://id.nlm.nih.gov/mesh/D009196Q000150 http://id.nlm.nih.gov/mesh/D015464Q000235 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D014633Q000235 http://id.nlm.nih.gov/mesh/D001549 http://id.nlm.nih.gov/mesh/D009196Q000235 http://id.nlm.nih.gov/mesh/D013922Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_54e32599939667ce8030f6c1725ceac0 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8561 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9409 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8870

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128458032 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654813

Total number of triples: 70.